Redmile Group, Llc Adc Therapeutics Sa (ADCT) insider trading activity
Redmile Group, LLC is > 10% Shareholder of ADC Therapeutics SA. Currently has a direct ownership of 13 Million shares of ADCT, which is worth approximately $40 Million. The most recent transaction as insider was on Jul 01, 2024, when has been sold 400,000 shares (Common Shares, par value CHF 0.08 per share) at a price of $2.81 per share, resulting in proceeds of $1,124,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
13M
n/a
3M change
n/a
12M change
Total Value Held
$40 Million
Redmile Group, LLC Transaction History
Also insider at
RGL
Redmile Group, LLC
> 10% Shareholder
San Francisco, CA